Evolent Health, Inc (EVH) financial statements (2021 and earlier)

Company profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
SIC 8741 - Management Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments344103228238179155
Cash and cash equivalents340101228238135146
Short-term investments42  449
Restricted cash and investments142015562345
Receivables1227278755120
Contract with customer, asset022
Other undisclosed current assets653224314
Total current assets:546229488378265184
Noncurrent Assets
Operating lease, right-of-use asset5872
Property, plant and equipment868574513113
Long-term investments and receivables22140132245
Long-term investments1713962245
Accounts and financing receivable, after allowance for credit loss517   
Intangible assets, net (including goodwill)6238811,103869885772
Goodwill355572768628627609
Intangible assets, net (excluding goodwill)268308335241259163
Contract with customer, asset, net 11
Capitalized contract cost, net273619
Restricted cash and investments786362
Other undisclosed noncurrent assets14618910 
Total noncurrent assets:8241,2691,234935935831
TOTAL ASSETS:1,3701,4981,7221,3131,2001,016
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16510622110811145
Accounts payable3237147434417
Accrued liabilities85334930296
Employee-related liabilities483525353822
Deferred revenue1420
Debt276    
Due to related parties  1   
Deferred revenue and credits252015
Contract with customer, liability21
Other undisclosed current liabilities1966127   
Total current liabilities:40219326913313260
Noncurrent Liabilities
Long-term debt and lease obligation32669    
Long-term debt, excluding current maturities263     
Operating lease, liability6369
Liabilities, other than long-term debt231519123621
Deferred revenue 1
Contract with customer, liability2
Deferred tax liabilities, net 22121
Deferred income tax liabilities12
Other liabilities22121710150
Other undisclosed noncurrent liabilities 292245121120 
Total noncurrent liabilities:34937626413415621
Total liabilities:75156953326628881
Stockholders' equity
Stockholders' equity attributable to parent, including:6209221,1441,011703649
Treasury stock, value(21)     
Additional paid in capital1,2291,1741,093924555342
Accumulated other comprehensive loss(0)(0)(0)   
Retained earnings (accumulated deficit)(589)(252)5086147307
Other undisclosed stockholders' equity attributable to parent111111
Stockholders' equity attributable to noncontrolling interest 74635210285
Total stockholders' equity:6209291,1891,046912935
TOTAL LIABILITIES AND EQUITY:1,3701,4981,7221,3131,2001,016

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,02284662743525497
Revenue, net43525497
Cost of revenue
(Policyholder Benefits and Claims Incurred, Net)
  (1)   
Gross profit:1,02284662643525497
Operating expenses(1,293)(1,153)(675)(508)(492)(140)
Other undisclosed operating income  1   
Operating loss:(271)(307)(47)(73)(237)(43)
Nonoperating income3342 414
Investment income, nonoperating3432 414
Interest and debt expense(33)(15)(5)(4)  
Income (loss) from continuing operations before equity method investments, income taxes:(301)(318)(49)(75)(237)371
Income (loss) from equity method investments10(9)(5)(2)(1)(28)
Other undisclosed income (loss) from continuing operations before income taxes(47)  010
Income (loss) from continuing operations before income taxes:(338)(327)(54)(76)(238)343
Income tax expense (benefit)422(0)711(23)
Net income (loss):(334)(306)(54)(70)(227)320
Net income attributable to noncontrolling interest 4296713
Net income (loss) attributable to parent:(334)(302)(53)(61)(160)332
Preferred stock dividends and other adjustments     (2)
Net income (loss) available to common stockholders, basic:(334)(302)(53)(61)(160)330
Convertible preferred dividends     2
Other undisclosed net loss available to common stockholders, diluted     (13)
Net income (loss) available to common stockholders, diluted:(334)(302)(53)(61)(160)320

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(334)(306)(54)(70)(227)320
Other undisclosed comprehensive loss(0)(0)(0)   
Comprehensive income (loss):(334)(306)(54)(70)(227)320
Comprehensive income, net of tax, attributable to noncontrolling interest 4296713
Comprehensive income (loss), net of tax, attributable to parent:(334)(302)(53)(61)(160)332

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: